Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Clasificación en acciones #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Precio por acción
$0.6
Última sincronización: 2024-08-14
Capitalización bursátil
$2.09M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
SG
Comercio ASLAN Pharmaceuticals Limited (ASLN)

Categoría

Historial de desdoblamientos de acciones de ASLAN Pharmaceuticals Limited (ASLN)
La acción ASLAN Pharmaceuticals Limited (símbolo: ASLN) tuvo un total de 2 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jul 03, 2024.
Una acción ASLN comprada antes de Mar 13, 2023 equivaldría hoy a 0.025 acciones ASLN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
2024-07-03 1:8 x0.125 x0.025
2023-03-13 1:5 x0.2 x0.2
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE